FAQ

MetaFlow is a physician-supervised, home-based, non-pharmacological execution system for chronic disease care.

MetaFlow uses a whole-person, root-cause-oriented, and systems-based approach to help patients and clinical teams identify the body’s current imbalance state and translate that state into a structured home-execution protocol. Rather than beginning with a single disease label or an isolated clinical marker, MetaFlow begins with each patient’s unique pattern of systemic imbalance and continuously tracks whether the body is moving toward a more stable health trajectory.

No. Nutrition, movement, sleep, stress management, and daily habits are important parts of the home-execution environment, but MetaFlow is not a generic lifestyle coaching program.

MetaFlow’s core intervention is an individualized, non-pharmacological, nature-driven execution signal protocol. Each protocol is tailored to the patient’s specific imbalance state and delivered through a structured home-based process under physician supervision. In other words, lifestyle is part of the execution environment. The individualized non-pharmacological signal protocol is MetaFlow’s core intervention layer.

No. MetaFlow does not replace primary care, specialist care, emergency care, or medication management. Medication decisions remain under the responsibility of the patient’s licensed treating clinicians. MetaFlow provides physician-supervised non-pharmacological home execution, structured tracking, risk review, reassessment, and protocol refinement.

MetaFlow currently focuses on two major areas: Cardio-Kidney-Metabolic health and Musculoskeletal health. This includes patients with patterns related to abnormal blood glucose, abnormal blood pressure, lipid abnormalities, fatty liver, atherosclerosis, kidney-related risk markers, chronic musculoskeletal pain, functional limitation, and long-term decline in mobility.

The process begins with a structured clinical review of the patient’s health history, symptoms, recent laboratory results, imaging records where available, medications, risk factors, and care context. MetaFlow then identifies the patient’s dominant imbalance patterns and generates a personalized home-execution protocol for physician review. During execution, patients track symptoms, adherence, tolerance, and functional changes, while monthly reassessment helps determine whether the protocol should continue, be adjusted, paused, or escalated for clinical review.

Physicians provide clinical oversight, review patient eligibility and risk, supervise protocol governance, evaluate red-flag concerns, and help determine whether a protocol should be continued, modified, paused, or escalated. MetaFlow is designed to make home execution structured, supervised, and accountable rather than disconnected from clinical review.

MetaFlow is not appropriate for every patient. Patients with red-flag symptoms, unstable clinical conditions, severe organ failure, active infection, significant immunosuppression, post-transplant status, or other high-risk features may be excluded or redirected to higher-level medical care. Safety screening, risk review, physician oversight, and escalation pathways are built into the MetaFlow model.

MetaFlow is now working with CMS through the ACCESS Model to seek real-world answers through a whole-person and root-cause-oriented approach. Through this framework, MetaFlow aims to evaluate whether physician-supervised, home-based, non-pharmacological execution can help improve chronic disease trajectories across CKM and MSK populations in real-world care.

MetaFlow tracks each patient’s trajectory across multiple dimensions, including symptoms, adherence, tolerance, pain, mobility, quality of life, and objective clinical markers where available. Depending on the patient’s condition and care context, reassessment will include laboratory testing, imaging follow-up, and functional review to evaluate whether the body is changing in a coordinated and clinically meaningful way.